tiprankstipranks
iX Biopharma Advances Rights cum Warrants Issue
Company Announcements

iX Biopharma Advances Rights cum Warrants Issue

iX Biopharma Ltd. (SG:42C) has released an update.

Maximize Your Portfolio with Data Driven Insights:

  • Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
  • Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio

iX Biopharma Ltd. has dispatched notification and application forms to eligible shareholders for its proposed Rights cum Warrants Issue, as previously detailed in announcements and the Offer Information Statement. Shareholders who haven’t received their forms can contact relevant parties for assistance. However, the offer is not available to foreign shareholders due to legal restrictions, and further updates will be provided as necessary.

For further insights into SG:42C stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App